Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early potent P2Y12 inhibitor monotherapy after IVUS-guided PCI in acute coronary syndrome
KCT0012027Phase 4Recruiting
- Sponsor
- Genoss
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, prasugrel, ticagrelor in acute coronary syndrome (ACS), sponsored by Genoss. Started Jul 2026; status: recruiting.
02
Drugs
aspirinprasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on KCT0012027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012027.